BILL NO. 112
(as introduced)
1st Session, 65th General Assembly
Nova Scotia
3 Charles III, 2025
Private Member's Public Bill
Access to PrEP Act
Lisa Lachance
Halifax Citadel–Sable Island
First Reading: March 25, 2025
Second Reading:
Third Reading:
Explanatory Note
This Bill amends the Fair Drug Pricing Act to provide coverage for antiviral drugs for the purpose of pre-exposure prophylaxis from HIV with no copayment.
An Act to Amend Chapter 7
of the Acts of 2011,
the Fair Drug Pricing Act,
to Expand Access to PrEP
Be it enacted by the Governor and Assembly as follows:
1 This Act may be cited as the Access to PrEP Act.
2 Chapter 7 of the Acts of 2011, the Fair Drug Pricing Act, is amended by adding immediately after Section 10 the following Section:
- 10A (1) Notwithstanding subsection 10(1), antiviral drugs for the purpose of pre-exposure prophylaxis from human immunodeficiency viruses are deemed to be a benefit.
(2) No copayment may be charged in connection with antiviral drugs for the purpose of pre-exposure prophylaxis from human immunodeficiency viruses.
This page and its contents published by the Office of the Legislative Counsel, Nova Scotia House of Assembly, and © 2025 Crown in right of Nova Scotia. Created March 25, 2025. Send comments to legc.office@novascotia.ca.
